Skip to main navigation
Skip to search
Skip to main content
Korea University Pure Home
Search content at Korea University Pure
Home
Profiles
Research units
Equipment
Research output
Press/Media
Monotherapy in patients with type 2 diabetes mellitus
Committee of Clinical Practice Guideline of Korean Diabetes Association
Department of Medicine
* World 2% Researchers
Research output
:
Contribution to journal
›
Review article
›
peer-review
6
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Monotherapy in patients with type 2 diabetes mellitus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetic Patients
100%
Monotherapy
100%
Metformin
66%
Mechanism of Action
33%
Type 1 Diabetes Mellitus (T1DM)
33%
Quality of Life
33%
Clinical Characteristics
33%
Diabetic Patients
33%
Combination Therapy
33%
Glucose-lowering Drugs
33%
Weight Gain
33%
Low Risk
33%
Clinical Situation
33%
Chronic Complications
33%
Glycemic Control
33%
Appropriate Treatment
33%
Low-side
33%
Drug Side Effects
33%
Low Weight
33%
Oral Hypoglycemic Agents
33%
Treatment Other
33%
Appropriate Medication
33%
Hypoglycemia Risk
33%
First Treatment
33%
Blood Glucose Reduction
33%
Intensive Lifestyle Intervention
33%
Diagnosis Stage
33%
Medicine and Dentistry
Drug Therapy
100%
Patient with Type 2 Diabetes
100%
Maturity Onset Diabetes of the Young
100%
Monotherapy
100%
Diabetes Mellitus
66%
Glycon
66%
Quality of Life
33%
Health Care Cost
33%
Combination Therapy
33%
Side Effect
33%
Antidiabetic Agent
33%
Blood Glucose
33%
Glycemic Control
33%
Lifestyle Modification
33%
Hypoglycemia
33%
Adverse Drug Reaction
33%
Nursing and Health Professions
Monotherapy
100%
Non Insulin Dependent Diabetes Mellitus
100%
Drug Therapy
100%
Patient with Type 2 Diabetes
100%
Diabetes Mellitus
66%
Metformin
66%
Glucose Blood Level
33%
Quality of Life
33%
Combination Therapy
33%
Side Effect
33%
Lifestyle Modification
33%
Hypoglycemia
33%
Antidiabetic Agent
33%
Adverse Drug Reaction
33%
Pharmacology, Toxicology and Pharmaceutical Science
Monotherapy
100%
Non Insulin Dependent Diabetes Mellitus
100%
Diabetes Mellitus
66%
Metformin
66%
Antidiabetic Agent
33%
Combination Therapy
33%
Side Effect
33%
Hypoglycemia
33%
Adverse Drug Reaction
33%